Artículos de revistas
Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells
Fecha
2017-10Registro en:
Herrera, María Inés; Mucci, Sofia; Barreto, George E; Kolliker Frers, Rodolfo Alberto; Capani, Francisco; Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells; Bentham Science Publishers; Current Pharmaceutical Design; 23; 26; 10-2017; 1-8
1381-6128
CONICET Digital
CONICET
Autor
Herrera, María Inés
Mucci, Sofia
Barreto, George E
Kolliker Frers, Rodolfo Alberto
Capani, Francisco
Resumen
Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the last decades, glial cells started to be considered as alternative targets for neuroprotection. Novel treatments for hypoxia-ischemia intend to modulate reactive forms of glial cells, and/or potentiate their recovery response. In this review, we summarize these neuroprotective strategies in hypoxia-ischemia and discuss their mechanisms of action.